BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 4064031)

  • 1. Clinical significance of different serum tumor markers in gynecological malignancies.
    Paulick R; Caffier H; Horner G; Lang K; Filbry E
    Cancer Detect Prev; 1985; 8(1-2):115-20. PubMed ID: 4064031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of serum CEA, PHI, and TPA as tumor markers in breast cancer patients.
    Paulick R; Caffier H; Paulick M
    Cancer Detect Prev; 1987; 10(3-4):197-203. PubMed ID: 3568016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of CA 125 in comparison to conventional tumor markers in ovarian cancer].
    Paulick R; Kaesemann H; Caffier H
    Geburtshilfe Frauenheilkd; 1986 Aug; 46(8):509-14. PubMed ID: 2875919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum tumor markers in metastatic breast cancer and course of disease.
    Caffier H; Brandau H
    Cancer Detect Prev; 1983; 6(4-5):451-7. PubMed ID: 6197167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significances of tissue polypeptide antigen in patients with gynecological malignancies].
    Ueda M; Sudo N; Furuya M; Arakawa O; Ikarashi T
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Nov; 37(11):2361-8. PubMed ID: 3001201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of CEA, TPA, GICA, CA 72.4, and CA 195 in the Diagnosis of primary colorectal cancer and at its relapse.
    Nicolini A; Caciagli M; Zampieri F; Ciampalini G; Carpi A; Spisni R; Colizzi C
    Cancer Detect Prev; 1995; 19(2):183-95. PubMed ID: 7750106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of serum tissue polypeptide antigen (TPA) in patients with urogenital cancer].
    Tozuka K; Yonese Y; Nakagami Y; Minowa T; Hiraoka Y; Yamada N; Hikima N; Ishii Y; Tannowa K; Fujioka Y
    Gan To Kagaku Ryoho; 1984 May; 11(5):1078-83. PubMed ID: 6721513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between serum levels of carcinoembryonic antigen, sialic acid and phosphohexose isomerase in lung cancer.
    Patel PS; Raval GN; Rawal RM; Patel GH; Balar DB; Shah PM; Patel DD
    Neoplasma; 1995; 42(5):271-4. PubMed ID: 8552208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The tumor markers TPA and CEA in the after care of breast cancer].
    Beaufort F; Fueger GF; Steiner H
    Wien Med Wochenschr; 1985 Feb; 135(4):85-8. PubMed ID: 2986366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A study on tumor marker of tissue-polypeptide-antigen (TPA) in gynecologic malignancies].
    Nakajima H; Hirata T; Norisugi T; Furuno K; Ikehata N; Utsunomiya A; Kobayashi K; Negishi Y; Akiya K
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Oct; 36(10):1877-83. PubMed ID: 6094688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tissue polypeptide antigen in gynecological cancer].
    Saitoh S; Nakanishi A; Noda T; Yoh S; Ando Y; Moriyama I; Ichijo M
    Gan No Rinsho; 1985 Jan; 31(1):65-72. PubMed ID: 3981803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of statistical discrimination employing serum TA-4, TPA, and CEA levels in uterine cervical cancer.
    Yabushita H; Ogawa A; Masuda T; Noguchi M; Nakanishi M; Ishihara M
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Oct; 38(10):1770-6. PubMed ID: 3782958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical usefulness of serum TPA, IAP and CEA levels in gynecological cancer].
    Saitoh S; Nakanishi A; Noda T; Ando Y; Kamamoto Y; Moriyama I; Ichijo M
    Nihon Gan Chiryo Gakkai Shi; 1984 Aug; 19(7):1496-504. PubMed ID: 6520506
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical evaluation of a combination assay of CEA, CA-19-9 and TPA in patients with colorectal cancer].
    Nishida O; Shiroto H; Satoh N; Nakajima Y; Manabe K; Kondoh Y; Sano F; Uchino J
    Gan No Rinsho; 1988 Aug; 34(9):1096-100. PubMed ID: 3172515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance of serum sialyl Tn antigen in patients with gynecological cancer. STN Study Group].
    Noda K; Shiota M; Tanizawa O; Inoue M; Tenjin Y; Sugishita T; Yakushiji M; Miyoshi T; Nozawa S; Sakuma T
    Gan To Kagaku Ryoho; 1991 Jul; 18(8):1287-96. PubMed ID: 2069400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoembryonic antigen in gynecologic patients. II. Immunohistological expression.
    Fenoglio CM; Crum CP; Pascal RR; Richart RM
    Diagn Gynecol Obstet; 1981; 3(4):291-9. PubMed ID: 7338157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of combined determination of CK19mRNA, carcinoembryanic antigen, neuron-specific enolase, and tissue polypeptide antigen in peripheral blood of patients with lung cancer].
    Pan QR; Zhang X; Xu ZF; Zheng S
    Ai Zheng; 2002 Feb; 21(2):196-9. PubMed ID: 12479076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The clinical significance of tissue polypeptide antigen (TPA) in the patients with gynecologic tumor].
    Inoue M; Inoue Y; Hiramatsu K; Tanaka Y; Yamasaki M; Ueda G; Minagawa J; Ozaki M; Yanagida T; Nishino H
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 May; 36(5):779-84. PubMed ID: 6736725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Importance of the tissue polypeptide antigen level in neoplastic patients. Its correlation with other tumor markers].
    Ruibal A; Durán P; Lafuerza A; Bodi R; Solé LA; Rubio D; Ibarz L; De Torres JA; Domenech-Torné FM; Salvador L
    Rev Esp Oncol; 1984; 31(3):409-14. PubMed ID: 6546169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical significance of vascular endothelial growth factor in sera of patients with gynaecological malignant tumors].
    Peng XP; Li JD; Li MD; Ye XM; Yan WC
    Ai Zheng; 2002 Feb; 21(2):181-5. PubMed ID: 12479072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.